New C-indices for assessing importance of longitudinal biomarkers in fitting competing risks survival data in the presence of partially masked causes
From MaRDI portal
Publication:6617488
DOI10.1002/sim.9671zbMATH Open1545.62555MaRDI QIDQ6617488
Joseph G. Ibrahim, M.D. Tuhin Sheikh, Ming-Hui Chen, Jonathan A. Gelfond, Wei Sun
Publication date: 11 October 2024
Published in: Statistics in Medicine (Search for Journal in Brave)
Cites Work
- Title not available (Why is that?)
- Title not available (Why is that?)
- A general joint model for longitudinal measurements and competing risks survival data with heterogeneous random effects
- Bayesian inference of the fully specified subdistribution model for survival data with competing risks
- Evaluating Prognostic Accuracy of Biomarkers under Competing Risk
- Time-Dependent Predictive Accuracy in the Presence of Competing Risks
- Assessing importance of biomarkers: A Bayesian joint modelling approach of longitudinal and survival data with semi-competing risks
- Joint modelling of longitudinal and survival data in the presence of competing risks with applications to prostate cancer data
- A Proportional Hazards Model for the Subdistribution of a Competing Risk
- Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker
- Bayesian Measures of Model Complexity and Fit
- Survival Model Predictive Accuracy and ROC Curves
- Bayesian survival analysis
- Flexible link functions in a joint hierarchical Gaussian process model
- Flexible longitudinal linear mixed models for multiple censored responses data
Related Items (1)
This page was built for publication: New C-indices for assessing importance of longitudinal biomarkers in fitting competing risks survival data in the presence of partially masked causes
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6617488)
